CPT® Code 88249

1. Indications

The chromosome analysis for breakage syndromes, CPT® Code 88249, is indicated for the evaluation of patients who exhibit symptoms suggestive of genetic disorders associated with chromosome instability. This includes, but is not limited to, the following conditions:

• Fanconi Anemia A genetic disorder leading to bone marrow failure and increased cancer risk, characterized by chromosomal breakage.
• Ataxia Telangiectasia A neurodegenerative disorder that affects coordination and immune function, associated with increased chromosome breakage.
• Fragile X Syndrome A genetic condition causing intellectual disability, often linked to chromosomal abnormalities.
• Other Breakage Syndromes Various genetic disorders that may present with similar symptoms and require chromosome analysis for diagnosis.

2. Procedure

The procedure for chromosome analysis for breakage syndromes involves several critical steps to ensure accurate results. First, peripheral blood lymphocytes are collected from the patient. These lymphocytes are then cultured in a controlled environment to stimulate cell division. The culture medium is supplemented with an aspecific antigen, such as phytohemagglutinin, which promotes lymphocyte proliferation. Following this, a spindle inhibitor is introduced to halt the cells in metaphase, preventing them from undergoing a second mitosis. This step is essential as it ensures that a sufficient number of mitotic cells are available for analysis.

Next, Bromo-deoxy-uridine (BrdU) is added to the culture medium, allowing for differential staining of the chromatids over the course of two complete cell cycles. This staining process is crucial for identifying exchanges between sister chromatids, which can indicate chromosomal abnormalities. Chromatids that incorporate only one strand of DNA will exhibit dark Giemsa staining, while those with two substituted strands will stain less intensely. If an exchange has occurred, the resulting chromosomes will display a characteristic pattern known as harlequin chromosomes.

In the specific context of CPT® Code 88249, 100 cells are scored during the analysis. A clastogen stress test is performed by exposing the cultured lymphocytes to clastogenic agents such as diepoxybutane or mitomycin C, or to ionizing or UV radiation. This stress testing is particularly important as it can reveal spontaneous chromosome breakage that may not be apparent under normal conditions. The application of these agents allows for the detection of breakage syndromes and aids in identifying the specific genotype associated with the condition, such as distinguishing between homozygotes and heterozygotes for Fanconi anemia.

3. Post-Procedure

After the chromosome analysis is completed, the results are carefully reviewed and interpreted by a qualified geneticist or cytogeneticist. The findings from the analysis can provide critical information regarding the presence of chromosomal abnormalities and the potential diagnosis of breakage syndromes. Patients may require follow-up consultations to discuss the implications of the results, potential treatment options, and any necessary genetic counseling. It is also important to monitor patients for any associated health issues that may arise from the identified genetic conditions. Documentation of the procedure and results is essential for ongoing patient management and for any future testing that may be required.